SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096148
Filing Date
2024-08-13
Accepted
2024-08-13 16:04:53
Documents
80
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q catx-20240630.htm   iXBRL 10-Q 1652294
2 EX-10.1 catx-ex10_1.htm EX-10.1 208239
3 EX-10.2 catx-ex10_2.htm EX-10.2 201120
4 EX-31.1 catx-ex31_1.htm EX-31.1 15259
5 EX-31.2 catx-ex31_2.htm EX-31.2 15244
6 EX-31.3 catx-ex31_3.htm EX-31.3 15464
7 EX-32 catx-ex32.htm EX-32 13815
  Complete submission text file 0000950170-24-096148.txt   8234185

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT catx-20240630.xsd EX-101.SCH 1344596
83 EXTRACTED XBRL INSTANCE DOCUMENT catx-20240630_htm.xml XML 1175686
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

IRS No.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33407 | Film No.: 241201301
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)